Background: Primary hypertrophic osteoarthropathy (PHOA1) is a rare genetic condition caused by mutation of the hydroxyprostaglandin dehydrogenase (HDPG) gene leading to prostaglandin excess, with digital clubbing, acro-osteolysis, periostitis, arthropathy and skin changes including pachyderma, hyperhydrosis and excessive facial furrowing [1] . Radiological findings previously described include plain radiographic changes with irregular periosteal proliferation, cortical thickening of long bones and acro-osteolysis. Bone scintigraphy identifies characteristic changes of symmetrically increased pericortical linear uptake of the tracer along the distal ends of long bones [2] . Joint US examination has been reported in one case only revealing synovitis and inflammation. Management options described in case reports include long-term NSAIDs, bisphosphonates, DMARDS, infliximab and arthroscopic synovectomy with variable symptomatic relief, and no improvement in established plain radiographic changes. Although the disease has been described as self-limiting, significant pain and disability is reported. Aims: We describe two unrelated children with clinical and radiological correlation, including the use of MRI, which has not previously been reported. Methods: Case 1: a 15-year-old male patient, previously diagnosed with PHOA1 in 2007 (homozygous mutation of the HDPG gene), was referred to paediatric rheumatology in 2012 with a year of progressive bilateral knee and leg pain. On examination he showed bony swelling of ankles and knees with restriction and marked finger clubbing. His older sister was also severely affected. Case 2: a 3-year-old female patient with consanguineous parents, the only affected child of six siblings, was diagnosed with homozygous mutation of the HDPG gene following a referral at 2 years of age with delayed walking. There was a history of surgical ligation for a large PDA at 4 months of age. On examination there was marked bilateral knee swelling with fixed flexion deformities and finger clubbing. Results: Case 1: MRI and plain radiographs were taken synchronously. Hand radiographs demonstrated soft tissue swelling and fingertip expansion but no acro-osteolysis. Otherwise, plain radiography showed normal bony appearances. MRI of knees and ankles showed effusions with synovial enhancement, marked periostitis affecting the patella and distal tibia, and tenosynovitis at the ankle with minimal change following treatment with a prolonged course of regular long-acting NSAIDs and a short course of steroids. Case 2: a skeletal survey demonstrated long bone diaphyseal periosteal reactions and acro-osteolysis affecting both hands and feet, consistent with hypertrophic osteoarthropathy. MRI revealed expanded, thickened and enhancing cortices suggesting periostitis. The surrounding muscle showed patchy oedema in keeping with an inflammatory condition. Conclusion: This is the first report of MRI changes in PHOA1. We plan to treat this disabling condition with pamidronate using serial MRI to monitor treatment response. Background: Chronic non-bacterial osteomyelitis (CNO) describes a spectrum of autoinflammatory bone disorders, characterized by single or multiple bony inflammatory lesions that can be monophasic or recurrent. When lesions are multiple and recurrent, the disease is termed chronic recurrent multifocal osteomyelitis (CRMO) [1, 2] . Aims: This study aims to describe CNO/CRMO patients managed by the Paediatric Rheumatology Department at Leeds General Infirmary over the last 4 years. Methods: Retrospective case notes review, focusing on patterns of referral, and clinical and radiological presentations. Results: Eight patients, with a median age of 11.5 years (range 7-18) were identified. Five patients were first referred to Orthopaedics, three to General Paediatrics and one to Paediatric Neurology. Paediatric Oncology was also involved in the early pathway of two patients. The median time between presentation of symptoms and referral to Paediatric Rheumatology was 24 months (range 12-72). The median time between symptom presentation and diagnosis of CRMO was 30 months (range 12-84). The most common presenting symptoms were intermittent pain and swelling. The degree of pain was variable and, in many, pain was exacerbated by exercise. The most common sites of lesions at presentation were the clavicle (3/8) and pelvis (3/8). All patients were investigated by X-ray imaging, seven had gadolinium contrast and STIR MRIs, and two also had an isotopic bone scan. In every patient, MRIs detected more lesions than X-rays, and in three patients MRI picked up lesions that were unexpected clinically. Bone biopsies were performed in six patients, of which two were inconclusive and four aided diagnosis by excluding malignancy and infection. ESR was raised in most patients. Five patients were treated first-line with NSAIDs; naproxen and diclofenac were the most common choices. Two patients received antibiotics, with no effect on CRMO lesions, and one had oral prednisolone. One patient also received MTX. Pamidronate infusions were either administered or planned in five cases. Conclusion: There were significant delays in referrals to Paediatric Rheumatology, which contributed to delay in diagnosis of CNO/ CRMO. The most common sites of presenting lesions were the clavicle and pelvis, and the vertebral column was often involved. MRI with gadolinium was the most useful investigation leading to diagnosis; it also helped to monitor disease progression and response to therapy. MRIs showed many lesions that would have gone undetected if only a plain radiograph had been performed. In our experience, patients can be mildly symptomatic in terms of pain and functional impairment, in spite of significant radiological changes. Disclosure statement: The authors have declared no conflicts of interest.
